Code | 18453 | ||||||||||
MA number | 44/0314/18-S | ||||||||||
Product Form: | plv ino 1x1 g (liek.inj.skl.) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
MAH, country: | Pfizer Europe MA EEIG, Belgium | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 60 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Subcutaneous and intravenous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 30.12.1970 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
SPC: | SPC_CYTOSAR 1 g_05.2024.pdf |
PIL: | PIL_CYTOSAR 1 g_06.2024.pdf |
Safety feature | Yes |
Data update: | 18.09.2018 |